Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Lowes	LOW	5. nov 2024	269.18	+1.59
LPL Financial	LPLA	5. nov 2024	275.81	+0.67
LQR House	LQR	5. nov 2024	0.72	-1.67
LSB Industries	LXU	5. nov 2024	8.56	+1.66
LSI Industries	LYTS	5. nov 2024	16.89	+1.81
Ltc Properties	LTC	5. nov 2024	37.94	+0.50
Lucas GC	LGCL	5. nov 2024	1.21	+4.31
Lucid Diagnostics	LUCD	5. nov 2024	0.94	+0.78
Lucid Group	LCID	5. nov 2024	2.25	+0.45
Lufax ADR	LU	5. nov 2024	2.63	+2.73
Lululemon Athletica	LULU	5. nov 2024	319.23	+0.35
Lulus Fashion Lounge	LVLU	5. nov 2024	1.72	+30.30
Lumen Technologies	LUMN	5. nov 2024	7.61	+1.74
Lument Finance Trust	LFT	5. nov 2024	2.52	+1.61
Lument Finance Trust A Pref	LFT-A	5. nov 2024	23.00	0.00
Lumentum	LITE	5. nov 2024	66.18	+3.13
Luminar Technologies A	LAZR	5. nov 2024	0.84	+4.76
Lumos Pharma	LUMO	5. nov 2024	4.39	-0.57
Luna Innovations	LUNA	5. nov 2024	1.57	-0.32
Luokung Technology	LKCO	5. nov 2024	1.69	-8.15
Luxfer	LXFR	5. nov 2024	14.47	+1.19
LuxUrban Hotels	LUXH	5. nov 2024	0.05	+34.42
Luxurban Hotels Pref	LUXHP	5. nov 2024	15.15	-0.39
Lxp Industrial Trust	LXP	5. nov 2024	9.29	0.00
LXP Industrial Trust C Pref	LXP-C	5. nov 2024	51.51	+1.55
Lyell Immunopharma	LYEL	5. nov 2024	1.24	-2.36
Lyft A	LYFT	5. nov 2024	13.80	+1.62
LyondellBasell Industries Nv A	LYB	5. nov 2024	85.37	+1.40
Lyra Therapeutics	LYRA	5. nov 2024	0.27	+1.75
Lytus Technologies	LYT	5. nov 2024	1.79	+6.55

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.